Better therapy of acute leukemias depends ultimately on better
understanding of the distinction between leukemic and normal
progenitor cells. This hugely important new book describes the
current knowledge of acute leukemia biology and discusses new
classification systems that have arisen as a result of emerging
insights into pathogenesis. Estey, Faderl and Kantarjian, who all
work at the respected Anderson Cancer Center in Houston, Texas,
USA, examine in detail advances in the treatment of particular
types of acute leukemia. Their book also covers the management of
acute leukemia in general as well as the development of new
therapies. This book will be extremely useful to clinicians.
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!